From major journals, first or last author from the Institute for Cancer Research
Eggebø MS, Heinzelbecker J, Palashati H, Chandler N, Tran TT, Li Y, Yang W, Laos M, Blaas I, Rustad EH, Bollineni RC, Delic-Sarac M, Lund-Johansen F, Nielsen MM, Olweus J(2025) TCR-engineered T cells targeting a shared β-catenin mutation eradicate solid tumors Nat Immunol(in press) DOI 10.1038/s41590-025-02252-1, PubMed 40866620
Ullern A, Holm K, Andresen NK, Røssevold AH, Bang C, Naume B, Hov JR, Kyte JA(2025) Gut microbiota diversity is prognostic in metastatic hormone receptor-positive breast cancer patients receiving chemotherapy and immunotherapy Mol Oncol(in press) DOI 10.1002/1878-0261.70117, PubMed 40852937
Foldvari Z, Brennan MS, Titov A, Jacobsen SEW, Olweus J(2025) Targeting the roots of myeloid malignancies with T cell receptors Nat Rev Cancer(in press) DOI 10.1038/s41568-025-00857-0, PubMed 40841587
Lindland K, Westrøm S, Dragovic SM, Li RG, Malenge MM, Ho B, Juzeniene A, Bønsdorff TB(2025) Preclinical Evaluation of PTK7-Targeted Radionuclide Therapy Mol Cancer Ther, 24(9), 1415-1427 DOI 10.1158/1535-7163.MCT-24-1060, PubMed 40495114
Sagini K, Selvarajah M, Romero S, Bassols-Citores E, Martin-Gracia B, Ramirez-Garrastacho M, Rise F, Endzeliņš E, Sadovska L, Skorinkina D, Boguševiča M, Cešeiko R, Čampa M, Klavina A, Linē A, Llorente A(2025) The Redox Enzyme Thioredoxin Is Increased in Plasma Extracellular Vesicles From Endurance-Trained Females in Response to Acute Exercise FASEB J, 39(16), e70927 DOI 10.1096/fj.202500678R, PubMed 40810354
Lindland K, Juzeniene A(2025) Cytotoxicity of 212Pb-labeled anti-PTK7 antibody in 2D adherent and 3D multicellular bladder cancer models EJNMMI Radiopharm Chem, 10(1), 58 DOI 10.1186/s41181-025-00382-3, PubMed 40885785